Executive Wealth Management, LLC Biogen Inc. Transaction History

Executive Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 30, 2019	SELL	$217.44 - $243.88 $10,872 - $12,194	-50 Reduced 80.65%	12 $2,000
Q2 2019 Aug 01, 2019	BUY	$219.29 - $241.72 $10,964 - $12,086	50 Added 416.67%	62 $14,000
Q1 2019 May 02, 2019	SELL	$216.71 - $338.96 $8,885 - $13,897	-41 Reduced 77.36%	12 $3,000
Q4 2018 Feb 19, 2019	BUY	$278.5 - $352.75 $14,760 - $18,695	53 New	53 $16,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Executive Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Executive Wealth Management, LLC with notifications on news.